Dr Reddy's Labs Q4 Results : Cons PAT jumps 22% to Rs 1,594 crore ; Rs 8 per share dividend (...)
Dr Reddy's Labs Q4 Results: Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.
Site référencé: The Economic Times
The Economic Times
Sebi mulls tweaking disclosure format for corporate governance framework by HVDLEs
9/05/2025
Defence stocks set to rally on export hopes amid rising India-Pakistan tensions : Ashika Equity
9/05/2025
PSU banks attract strong FII, DII interest as promoters reduce exposure : Motilal Oswal
9/05/2025
India-Pakistan conflict : No military solution possible, it will ultimately be a political solution : Swaminathan Aiyar
9/05/2025
Ravi Infrabuild Projects files draft papers with Sebi to raise Rs 1,100 cr through IPO
9/05/2025
India’s Kamikaze drone strike on Pakistan boosts this Israeli stock with an Adani connection
9/05/2025
